Subscribe To
Why shares of savara soared this week
The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases....
January 27, 2023, 3:47 pm
Is teva pharmaceutical industries (teva) a great value stock right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
January 27, 2023, 11:17 am
Bears are losing control over recursion pharmaceuticals (rxrx), here's why it's a 'buy' now
After losing some value lately, a hammer chart pattern has been formed for Recursion pharmaceuticals (R...
January 27, 2023, 11:17 am
Mckesson (mck) to report q3 earnings: is a beat in the cards?
McKesson's (MCK) fiscal third-quarter results are likely to reflect the solid display by the U.S. pharmaceutic...
January 27, 2023, 10:32 am
Regeneron, sanofi's dupixent is one step closer to approval for young children in europe
Shares of Regeneron pharmaceuticals Inc. REGN, +0.15% gained about 2.5% in premarket trading on Friday ...
January 27, 2023, 8:27 am
Invox pharma and f-star therapeutics issue joint statement
LONDON, Jan. 26, 2023 (GLOBE NEWSWIRE) — invoX Pharma (“invoX”), a wholly owned subsidiary of Sino Bioph...
January 26, 2023, 8:47 pm
23andme to report fy2023 third quarter financial results
SOUTH SAN FRANCISCO, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and bio...
January 26, 2023, 4:05 pm
Syneos health (synh) signs new partnership with cryoport
Syneos Health (SYNH) inks a partnership with Cryoport to deliver seamless integration and insights for key services for cell and gene trial operations...
January 26, 2023, 12:02 pm
Down 30% in a day, is catalyst pharmaceuticals doomed?
Things aren't as bad as they might seem....
January 26, 2023, 9:22 am
3 top-rated profitable stocks to buy using net income ratio
Lamb Weston (LW), Pinduoduo (PDD), and Catalyst pharmaceuticals (CPRX) have been selected as the top pi...
January 26, 2023, 7:32 am
Zyversa therapeutics to present at bio ceo & investor conference
WESTON, Fla., Jan. 25, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty bio...
January 25, 2023, 9:45 am
Why is sonoma pharmaceuticals (snoa) up 70% today?
Sonoma pharmaceuticals (NASDAQ: SNOA ) stock is rocketing higher on Wednesday following positive news f...
January 25, 2023, 9:23 am
Kalvista pharmaceuticals: the share price rally requires an adjustment of my investment thesis
KalVista intends to provide best-in-class therapies, both for acute on-demand and prophylaxis treatment, to fundamentally change the way HAE is treate...
January 25, 2023, 8:30 am
Lonza fy22 profit up, lifts dividend; sees higher fy23 sales, weak margin; plans chf 2 bln buyback
Lonza Group AG (LZAGF.PK), a supplier to the pharmaceutical, healthcare and life-science industries, re...
January 25, 2023, 7:14 am
3 reasons to buy abbvie and 2 reasons not to buy
The pharmaceutical specialist is facing a pivotal year in 2023, thanks to growing competition....
January 25, 2023, 7:05 am
Taro pharmaceutical (taro) lags q3 earnings and revenue estimates
Taro (TARO) delivered earnings and revenue surprises of -78.16% and 14.66%, respectively, for the quarter ended December 2022. Do the numbers hold clu...
January 24, 2023, 8:19 pm
Johnson & johnson's 4q earnings beat and rosy 2023 outlook fails to distract from slowing sales growth and inflationary pressures
Johnson & Johnson (NYSE:JNJ)'s rosy 2023 earnings forecast failed to take the sting off of moderated sales growth and inflationary pressures during th...
January 24, 2023, 1:37 pm
Tonix pharmaceuticals announces publication of paper in antiviral research highlighting the company’s development of monoclonal antibody therapeutics for monkeypox and smallpox
Data Represent Research and Development Work Being Conducted at Tonix’s Infectious Disease R&D Center (RDC) in Frederick, Md. CHATHAM, N.J., Jan. 24...
January 24, 2023, 12:00 pm
When does pfizer become a bargain?
The pharmaceutical company Pfizer Inc. (NYSE: PFE) saw its shares become very popular after creating on...
January 24, 2023, 11:46 am
Strength seen in tarsus pharmaceuticals, inc. (tars): can its 5.0% jump turn into more strength?
Tarsus pharmaceuticals, Inc. (TARS) saw its shares surge in the last session with trading volume being ...
January 24, 2023, 6:01 am